Tirzepatide and Orforglipron
"Xi'an Greday Biological Technology has completed small-scale synthesis and purity calibration of Tirzepatide and Orforglipron APIs, and can supply API powder, formulation development support and pilot-scale contract manufacturing, entering the GLP-1 innovative API market."
Core Weight-Loss & Glucose-Lowering APIs
Leveraging the technical capabilities of our university-enterprise joint laboratory, we have completed small-scale sample synthesis and purity calibration of two core Eli Lilly-originated weight-loss and glucose-lowering APIs — Tirzepatide and Orforglipron. We can reliably supply API powder, injectable formulation development support, and pilot-scale formulation contract manufacturing, formally entering the fast-growing global GLP-1 innovative API market and upgrading our portfolio from basic generics to high-end specialty APIs.

Figure: Molecular structure diagram of GLP-1 innovative APIs
Welcome to contact us to discuss API supply and contract manufacturing cooperation.